معرفی
Prof. Jorma Hinkula is a Professor of Molecular Virology at Linköping University's Department of Biomedical and Clinical Sciences (BKV), under the Division of Molecular Medicine and Virology. He leads research into vaccines and antiviral therapies targeting HIV-1, influenza, rotaviruses, and Crimean-Congo hemorrhagic fever. His work integrates virology, immunology, and nanotechnology to develop innovative biomedical solutions.
Education:
- PhD in Medical Sciences (1993)
- Bachelor of Science in Biomedical Laboratory Sciences (1989)
Research Interests: His lab focuses on:
- Vaccine design using nanotechnology and virus-like particles
- Host-virus interactions, particularly complement opsonization effects on immune cells
- Pre-clinical evaluation of nanovaccines in collaboration with University College London
Recent Article Trends: His 2024 work explores lipid-based adjuvants and coacervate nanostructures for vaccines, while 2023 studies highlight sex-specific immune responses in diabetic populations. Earlier 2022 research includes antiviral peptides against SARS-CoV-2 and flaviviruses.
Advising & Grants: He supervises postdoctoral fellows in the MIIC Program and manages BSL3 laboratory operations. His team collaborates globally on vaccine development and 3D tissue culture models.
Labs/Teams: The Division of Molecular Medicine and Virology (MMV) supports his interdisciplinary research, combining basic science with clinical translation.
